Skip to search
Skip to main content
Back to Search
Start Over
CARFILZOMIB AND DEXAMETHASONE VS SUBCUTANEOUS BORTEZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA: SECONDARY ANALYSIS FROM THE PHASE 3 STUDY ENDEAVOR (NCT01568866)
Authors :
Goldschmidt, H. Moreau, P. Palumbo, A. Joshua, U. Pour, L. Roman Hajek Facon, T. Ludwig, H. Niesvizky, R. Oriol, A. Rosinol, L. Straub, J. Suvorov, A. Araujo, C. Rimashevskaya, E. Pika, T. Gaidano, G. Weisel, K. Goronova-Marinova, V. Schwarer, A. Minuk, L. Masszi, T. Karamanesht, I. Offidani, M. Hungria, V. Spencer, A. Orlowski, R. Iskander, K. Feng, S. Aggarwal, S. Chng, W. J. Dimopoulos, Ma
Source :
ResearcherID, Web of Science
Details
Database :
OpenAIRE
Journal :
ResearcherID, Web of Science
Accession number :
edsair.dedup.wf.001..4cbe3280ca904167a3765814cf46c77b